JNJ-26528398

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-26528398, covering 2013-06-24 to 2013-06-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacodynamic Activity of JNJ-26528398 in Healthy Male Participants [Phase 1]